NCT03101189View on ClinicalTrials.gov

A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

April 24, 2017

Study Completion Date

April 26, 2017

Conditions
Healthy Subjects
Interventions
DRUG

ACT-541468

Capsule

DRUG

placebo

Matching placebo capsule

Trial Locations (1)

Unknown

Centre for Human Drug Research, Leiden

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03101189 - A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter